In advanced PAH, circulating B-type natriuretic peptide (BNP) levels are typically very high, which would predict increased cardiac PDE9A expression as a compensatory response to degrade NP-generated cGMP. The gene discussed is PDE9A; the disease is pulmonary arterial hypertension.